Bal Pharma Limited Total Liabilities

Latest as of June 2026: Rs-822.52 Million INR ≈ $-8.90 Million USD

Bal Pharma Limited total liabilities. Based on the latest financial reports, Bal Pharma Limited (BALPHARMA) has total liabilities worth Rs-822.52 Million INR (≈ $-8.90 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Bal Pharma Limited liquidity resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Bal Pharma Limited (2006–2026)

Total liabilities of Bal Pharma Limited from 2006 to 2026. This chart illustrates how Bal Pharma Limited's total liabilities have evolved over time, based on quarterly financial data. Explore Bal Pharma Limited (BALPHARMA) long-term investment share to see how much of total assets are deployed in long-term investments.

Bal Pharma Limited Competitors by Total Liabilities

The table below lists competitors of Bal Pharma Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Sequoia Econ Infrastructure LSE:SEQI	UK	GBX25.76 Million
Digicontent Limited NSE:DGCONTENT	India	Rs2.16 Billion
Goodwin PLC LSE:GDWN	UK	GBX187.45 Million
Tungray Technologies Inc Class A Ordinary Shares NASDAQ:TRSG	USA	$11.48 Million
Energoaparatura S.A. WAR:ENP	Poland	zł16.36 Million
Ark Mines Ltd AU:AHK	Australia	AU$774.19K
Altamin Ltd AU:AZI	Australia	AU$1.03 Million
Truwin Co Ltd KQ:105550	Korea	₩55.37 Billion

Liability Composition Analysis (2006–2026)

This chart breaks down Bal Pharma Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Bal Pharma Limited asset portfolio.

Liquidity & Leverage Metrics

Bal Pharma Limited Total Liabilities Ratios Explained

Bal Pharma Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	N/A	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.00	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	N/A	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bal Pharma Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bal Pharma Limited (2006–2026)

The table below shows the annual total liabilities of Bal Pharma Limited from 2006 to 2026.

Year	Total Liabilities	Change
2026-03-31	Rs2.93 Billion ≈ $31.72 Million	+13.55%
2025-03-31	Rs2.58 Billion ≈ $27.93 Million	+3.21%
2024-03-31	Rs2.50 Billion ≈ $27.07 Million	+0.32%
2023-03-31	Rs2.49 Billion ≈ $26.98 Million	+23.48%
2022-03-31	Rs2.02 Billion ≈ $21.85 Million	+8.20%
2021-03-31	Rs1.87 Billion ≈ $20.19 Million	-3.28%
2020-03-31	Rs1.93 Billion ≈ $20.88 Million	-4.00%
2019-03-31	Rs2.01 Billion ≈ $21.75 Million	+4.94%
2018-03-31	Rs1.92 Billion ≈ $20.72 Million	+12.59%
2017-03-31	Rs1.70 Billion ≈ $18.41 Million	+8.88%
2016-03-31	Rs1.56 Billion ≈ $16.90 Million	+43.80%
2015-03-31	Rs1.09 Billion ≈ $11.75 Million	+3.82%
2014-03-31	Rs1.05 Billion ≈ $11.32 Million	-0.50%
2013-03-31	Rs1.05 Billion ≈ $11.38 Million	+4.07%
2012-03-31	Rs1.01 Billion ≈ $10.93 Million	+2.00%
2011-03-31	Rs991.28 Million ≈ $10.72 Million	+12.09%
2010-03-31	Rs884.40 Million ≈ $9.56 Million	+4.91%
2009-03-31	Rs843.01 Million ≈ $9.12 Million	+14.22%
2008-03-31	Rs738.08 Million ≈ $7.98 Million	+29.20%
2007-03-31	Rs571.26 Million ≈ $6.18 Million	+2.38%
2006-03-31	Rs558.01 Million ≈ $6.03 Million	--

About Bal Pharma Limited

NSE:BALPHARMA India Drug Manufacturers - Specialty & Generic

Market Cap

$14.08 Million

Rs1.30 Billion INR

Market Cap Rank

#26014 Global

#1441 in India

Share Price

Rs81.80

Change (1 day)

+1.23%

52-Week Range

Rs60.42 - Rs114.45

All Time High

Rs151.23